Top 10 Key Players companies in PCSK9 Inhibitors by Most Research Publications in the United States in 2019 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Research Publications PCSK9 Inhibitors Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	The Brigham & Women's Hospital, Inc.	Massachusetts, United States	Health care,Mitral valve surgery,Health equity, ...[+2]	Literature: 6
2	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Literature: 5
3	Regeneron Pharmaceuticals, Inc.	New York, United States	Monoclonal antibody,Clinical trial,Cholesterol, ...[+2]	Literature: 2
4	Beth Israel Deaconess Medical Center, Inc.	Massachusetts, United States	Medical school,Clinical research,Health care, ...[+2]	Literature: 2
5	Cardiovascular Institute of the South	Louisiana, United States	Vascular Medicine,Health care,Lipid management, ...[+2]	Literature: 2
6	Baptist Hospital of Miami, Inc.	United States	Physician self-referral,Health care,Hospitality industry, ...[+2]	Literature: 2
7	Esperion Therapeutics, Inc.	Michigan, United States	Medicine,Health care,Cardiovascular agent, ...[+2]	Literature: 1
8	Medpace, Inc.	Ohio, United States	Clinical research,Drug discovery,Contract research organization, ...[+2]	Literature: 1
9	North Shore University Hospital	New York, United States	Medical robot,Robotics,Medicine, ...[+2]	Literature: 1
10	Cleveland Clinic	OH, US	Health care,Face transplant,Coronary artery bypass surgery, ...[+2]	Literature: 1